Polymerase News and Research

RSS
Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

Using Hla-A*32 allele as a prognostic indicator of COVID-19 severity

2 Mar 2022
Similarities between SARS-CoV-2 and human retroelements explored

Similarities between SARS-CoV-2 and human retroelements explored

2 Mar 2022
Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

2 Mar 2022
The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

2 Mar 2022
Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

2 Mar 2022
mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

1 Mar 2022
Risk of death involving COVID-19 following infection from Omicron relative to Delta

Risk of death involving COVID-19 following infection from Omicron relative to Delta

1 Mar 2022
Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

1 Mar 2022
Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

1 Mar 2022
Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

1 Mar 2022
Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

1 Mar 2022
Novel coronavirus identified in Swedish bank voles

Novel coronavirus identified in Swedish bank voles

1 Mar 2022
Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

1 Mar 2022
A study on the evolution of avian coronavirus escape mutants in vitro

A study on the evolution of avian coronavirus escape mutants in vitro

28 Feb 2022
Breakthrough SARS-CoV-2 infection peaks at 5 months

Breakthrough SARS-CoV-2 infection peaks at 5 months

28 Feb 2022
Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

28 Feb 2022
Vaccination reduces risk of long-COVID

Vaccination reduces risk of long-COVID

27 Feb 2022
Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

25 Feb 2022
mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

25 Feb 2022
Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

Foundational characterization of a new bat-borne ebolavirus and its potential as a human pathogen

24 Feb 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback